VasoCollar Inc.
Selected as a startup company by FINDIT Matchmaking in the past two years
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
VasoCollar(Rapid Vascular Anastomosis and Blood Flow Restoration Solutions)
The content above was translated by Ai
Founded Year
2018
Unified Business No.
42915379
Status
Active
Number of Employees
0
Total Paid-in
Capital
7,685,356 (NT$)
Location of Company
Taiwan
, Tainan City
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
At VasoCollar, we transform physicians' needs into innovative, standardized solutions to address critical clinical challenges—specifically, rapid vascular anastomosis and blood flow restoration. We have proof-of-concept data for 2.5 mm and 5 mm vessels in trauma and plastic surgery and have applied for four patents in the USA, China, and Taiwan since 2020. Our initial market focus is trauma, and we have secured a contract with the U.S. Department of Defense in 2014, and collaborate with Brooke Army Medical Center and Stanford Medicine in 2025. With FDA approval expected in 2026, we will launch 20 clinical trials for market entry. We are currently raising $1.5 million in angel investment to finalize product design, scale mass production, and achieve FDA approval by the end of 2026.
The content above was translated by Ai
